Cas:959604-71-8 N’-(4-chlorophenyl)-1-methylimidazole-4-carboximidamide manufacturer & supplier

Chemical Name:N’-(4-chlorophenyl)-1-methylimidazole-4-carboximidamide

CAS.NO:959604-71-8

Synonyms:N’-(4-chlorophenyl)-1-methyl-4-imidazolecarboximidamide;N-(4-Chlorophenyl)1-methyl-1H-imidazole-4-carboximidamide;I14-4952;N-(4-Chlorophenyl)-1-methyl-1H-imidazole-4-carboximidamide;1H-Imidazole-4-carboximidamide, N-(4-chlorophenyl)-1-methyl-

Molecular Formula:C₁₁H₁₁ClN₄

Molecular Weight:234.685

HS Code:2933290090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:407.4±51.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.645

PSA:53.70000

Exact Mass:234.067230

LogP:2.04

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N’-(4-chlorophenyl)-1-methyl-4-imidazolecarboximidamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Imidazole-4-carboximidamide, N-(4-chlorophenyl)-1-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Imidazole-4-carboximidamide, N-(4-chlorophenyl)-1-methyl- Use and application,1H-Imidazole-4-carboximidamide, N-(4-chlorophenyl)-1-methyl- technical grade,usp/ep/jp grade.

Related News: Improved gene mining techniques have permitted previously uncharacterized gene clusters to be discovered, while advances in heterologous expression and production have allowed the encoded enzymes to rapidly be scaled up and evaluated as tools for organic synthesis. 1,2,4-Triazin-5(4H)-one, 3-(ethylthio)-4-methyl-6-(1-methylpropyl)- manufacturers In response, the strategy sets out how government will work with institutions, businesses, funders and charities to drive change in the sector, with new initiatives to encourage more young people into research, broaden career pathways in the sector and look further into the impacts of bureaucracy on researchers. 1,2,2,3-tetramethylpiperidine suppliers The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). Poly[oxy(methyl-1,2-ethanediyl)oxycarbonylnaphthalenediylcarbonyl] vendor & factory.